U.S. Markets open in 8 hrs 5 mins

Novartis Enters Agreement to Acquire AveXis

Mike Benson
Novartis Enters Agreement to Acquire AveXis

On April 9, 2018, Novartis AG (NVS) announced that it had entered into an agreement to acquire AveXis (AVXS), a clinical-stage gene therapy company, for ~$8.7 billion.